Microbot Medical Inc. (NASDAQ:MBOT) Director Yoseph Bornstein sold 50,000 shares of Microbot Medical stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $1.14, for a total transaction of $57,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Yoseph Bornstein also recently made the following trade(s):

  • On Tuesday, October 17th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.16, for a total transaction of $58,000.00.
  • On Tuesday, October 10th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.38, for a total transaction of $69,000.00.
  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.49, for a total transaction of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.20, for a total transaction of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.24, for a total transaction of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.18, for a total transaction of $59,000.00.
  • On Tuesday, September 12th, Yoseph Bornstein sold 20,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.12, for a total transaction of $22,400.00.
  • On Wednesday, September 6th, Yoseph Bornstein sold 45,610 shares of Microbot Medical stock. The stock was sold at an average price of $1.01, for a total transaction of $46,066.10.

Microbot Medical Inc. (NASDAQ MBOT) remained flat at $1.11 during trading on Thursday. 476,101 shares of the stock traded hands. Microbot Medical Inc. has a 12 month low of $1.00 and a 12 month high of $15.66. The stock’s market capitalization is $48.89 million. The stock has a 50-day moving average of $1.21 and a 200 day moving average of $2.17.

Microbot Medical (NASDAQ:MBOT) last posted its quarterly earnings results on Monday, August 14th. The biotechnology company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.48) by $0.44. On average, equities analysts predict that Microbot Medical Inc. will post ($25.02) EPS for the current year.

WARNING: “Microbot Medical Inc. (MBOT) Director Sells $57,000.00 in Stock” was reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/26/microbot-medical-inc-mbot-director-sells-57000-00-in-stock.html.

An institutional investor recently bought a new position in Microbot Medical stock. Sabby Management LLC bought a new stake in shares of Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned 2.92% of Microbot Medical as of its most recent filing with the Securities and Exchange Commission. 4.66% of the stock is owned by institutional investors.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.